BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12198618)

  • 1. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease.
    Humar A; Kumar D; Boivin G; Caliendo AM
    J Infect Dis; 2002 Sep; 186(6):829-33. PubMed ID: 12198618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.
    Humar A; Kumar D; Gilbert C; Boivin G
    J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation.
    Sia IG; Wilson JA; Groettum CM; Espy MJ; Smith TF; Paya CV
    J Infect Dis; 2000 Feb; 181(2):717-20. PubMed ID: 10669361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
    Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
    Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human beta-herpesvirus interactions in solid organ transplant recipients.
    Mendez JC; Dockrell DH; Espy MJ; Smith TF; Wilson JA; Harmsen WS; Ilstrup D; Paya CV
    J Infect Dis; 2001 Jan; 183(2):179-184. PubMed ID: 11120923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
    Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir.
    Razonable RR; van Cruijsen H; Brown RA; Wilson JA; Harmsen WS; Wiesner RH; Smith TF; Paya CV
    J Infect Dis; 2003 Jun; 187(11):1801-8. PubMed ID: 12751039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.
    Ghisetti V; Barbui A; Franchello A; Varetto S; Pittaluga F; Bobbio M; Salizzoni M; Marchiaro G
    J Med Virol; 2004 Jun; 73(2):223-9. PubMed ID: 15122796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
    Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD
    J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective assessment of cytomegalovirus immune evasion gene transcription profiles in transplant patients with cytomegalovirus infection.
    Humar A; Kumar D; Gray M; Moussa G; Venkataraman S; Kumar R; Tipples GA
    Transplantation; 2007 May; 83(9):1200-6. PubMed ID: 17496536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
    Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J
    Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.
    Lurain NS; Bhorade SM; Pursell KJ; Avery RK; Yeldandi VV; Isada CM; Robert ES; Kohn DJ; Arens MQ; Garrity ER; Taege AJ; Mullen MG; Todd KM; Bremer JW; Yen-Lieberman B
    J Infect Dis; 2002 Sep; 186(6):760-8. PubMed ID: 12198609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.
    Roblin X; Pillet S; Oussalah A; Berthelot P; Del Tedesco E; Phelip JM; Chambonnière ML; Garraud O; Peyrin-Biroulet L; Pozzetto B
    Am J Gastroenterol; 2011 Nov; 106(11):2001-8. PubMed ID: 21788989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.
    Loginov R; Höckerstedt K; Lautenschlager I
    Arch Virol; 2003 Jul; 148(7):1269-74. PubMed ID: 12827460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient.
    García-Martínez J; Folgueira L; Delgado R; Hernando S; Prieto C; Aguado JM; Otero JR
    Transpl Infect Dis; 2008 Apr; 10(2):123-8. PubMed ID: 17605746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP
    Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
    Mylonakis E; Kallas WM; Fishman JA
    Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.